
Justin R. Blaufeld
Examiner (ID: 11783)
| Most Active Art Unit | 2142 |
| Art Unit(s) | 2151, 2176, 2198, 2142 |
| Total Applications | 587 |
| Issued Applications | 244 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16870473
[patent_doc_number] => 20210163940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => COMPOSITIONS AND METHODS FOR NICKING TARGET DNA SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 17/083918
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17083918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/083918 | COMPOSITIONS AND METHODS FOR NICKING TARGET DNA SEQUENCES | Oct 28, 2020 | Abandoned |
Array
(
[id] => 16793229
[patent_doc_number] => 20210123046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => OPTIMIZED SMALL GUIDE RNAS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/033255
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17033255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/033255 | Optimized small guide RNAs and methods of use | Sep 24, 2020 | Issued |
Array
(
[id] => 17474188
[patent_doc_number] => 20220081692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => Combinatorial Assembly of Composite Arrays of Site-Specific Synthetic Transposons Inserted Into Sequences Comprising Novel Target Sites in Modular Prokaryotic and Eukaryotic Vectors
[patent_app_type] => utility
[patent_app_number] => 17/013546
[patent_app_country] => US
[patent_app_date] => 2020-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013546
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/013546 | Combinatorial Assembly of Composite Arrays of Site-Specific Synthetic Transposons Inserted Into Sequences Comprising Novel Target Sites in Modular Prokaryotic and Eukaryotic Vectors | Sep 4, 2020 | Pending |
Array
(
[id] => 16839867
[patent_doc_number] => 20210147879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Large Gene Excision and Insertion
[patent_app_type] => utility
[patent_app_number] => 16/989119
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989119 | Large Gene Excision and Insertion | Aug 9, 2020 | Pending |
Array
(
[id] => 17850530
[patent_doc_number] => 20220280571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIA
[patent_app_type] => utility
[patent_app_number] => 17/631240
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21265
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631240
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631240 | COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIA | Jul 30, 2020 | Pending |
Array
(
[id] => 16513281
[patent_doc_number] => 20200392539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => CRISPR ENABLED MULTIPLEXED GENOME ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 16/938739
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938739 | CRISPR enabled multiplexed genome engineering | Jul 23, 2020 | Issued |
Array
(
[id] => 16437423
[patent_doc_number] => 20200354749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
[patent_app_type] => utility
[patent_app_number] => 16/935023
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16935023
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/935023 | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription | Jul 20, 2020 | Issued |
Array
(
[id] => 16437422
[patent_doc_number] => 20200354748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
[patent_app_type] => utility
[patent_app_number] => 16/935016
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16935016
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/935016 | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription | Jul 20, 2020 | Issued |
Array
(
[id] => 17749966
[patent_doc_number] => 20220228171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => COMPOSITIONS AND PRODUCTION OF NICKED CLOSED-ENDED DNA VECTORS
[patent_app_type] => utility
[patent_app_number] => 17/617330
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -133
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617330
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617330 | COMPOSITIONS AND PRODUCTION OF NICKED CLOSED-ENDED DNA VECTORS | Jul 16, 2020 | Pending |
Array
(
[id] => 17762658
[patent_doc_number] => 20220236270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => THE DOUBLE DEAMIDATED FORM OF BCL-XL IS A BIOMARKER OF PLATELET AGE
[patent_app_type] => utility
[patent_app_number] => 17/617617
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617617 | Double deamidated form of Bcl-xL is a biomarker of platelet age | Jun 10, 2020 | Issued |
Array
(
[id] => 17897068
[patent_doc_number] => 20220306730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => METHODS OF TREATING CANCER BY TARGETING ZSCAN4 ACTIVITY IN CANCER STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/613443
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/613443 | Methods of treating cancer by targeting ZSCAN4 activity in cancer stem cells | May 21, 2020 | Issued |
Array
(
[id] => 16673483
[patent_doc_number] => 20210062246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => METHODS OF DIAGNOSING INFECTIOUS DISEASE PATHOGENS AND THEIR DRUG SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 16/877372
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877372 | METHODS OF DIAGNOSING INFECTIOUS DISEASE PATHOGENS AND THEIR DRUG SENSITIVITY | May 17, 2020 | Abandoned |
Array
(
[id] => 16266505
[patent_doc_number] => 20200267992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
[patent_app_type] => utility
[patent_app_number] => 16/858333
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858333
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858333 | Altering microbial populations and modifying microbiota | Apr 23, 2020 | Issued |
Array
(
[id] => 16328766
[patent_doc_number] => 20200299732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => RNA-Guided Transcriptional Regulation
[patent_app_type] => utility
[patent_app_number] => 16/851360
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/851360 | RNA-Guided Transcriptional Regulation | Apr 16, 2020 | Pending |
Array
(
[id] => 18242489
[patent_doc_number] => 20230074800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => CAR-T CELL THERAPIES WITH ENHANCED EFFICACY
[patent_app_type] => utility
[patent_app_number] => 17/441576
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -116
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/441576 | CAR-T CELL THERAPIES WITH ENHANCED EFFICACY | Mar 19, 2020 | Pending |
Array
(
[id] => 16791764
[patent_doc_number] => 20210121581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS
[patent_app_type] => utility
[patent_app_number] => 16/818229
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818229
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818229 | METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS | Mar 12, 2020 | Abandoned |
Array
(
[id] => 20329933
[patent_doc_number] => 12460200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Methods and compositions comprising CRISPR-Cpf1 and paired guide CRISPR RNAs for programmable genomic deletions
[patent_app_type] => utility
[patent_app_number] => 16/806197
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 31
[patent_no_of_words] => 13611
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806197
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806197 | Methods and compositions comprising CRISPR-Cpf1 and paired guide CRISPR RNAs for programmable genomic deletions | Mar 1, 2020 | Issued |
Array
(
[id] => 16112231
[patent_doc_number] => 20200208138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => GENOMIC SEQUENCE MODIFICATION METHOD FOR SPECIFICALLY CONVERTING NUCLEIC ACID BASES OF TARGETED DNA SEQUENCE, AND MOLECULAR COMPLEX FOR USE IN SAME
[patent_app_type] => utility
[patent_app_number] => 16/791968
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15373
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791968 | Genomic sequence modification method for specifically converting nucleic acid bases of targeted DNA sequence, and molecular complex for use in same | Feb 13, 2020 | Issued |
Array
(
[id] => 15827101
[patent_doc_number] => 20200128832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
[patent_app_type] => utility
[patent_app_number] => 16/737793
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737793
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737793 | ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA | Jan 7, 2020 | Abandoned |
Array
(
[id] => 19969860
[patent_doc_number] => 12338453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Method for the introduction of genetic information in cell by site-specific integration system
[patent_app_type] => utility
[patent_app_number] => 17/414292
[patent_app_country] => US
[patent_app_date] => 2019-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 32
[patent_no_of_words] => 25091
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17414292
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/414292 | Method for the introduction of genetic information in cell by site-specific integration system | Dec 16, 2019 | Issued |